ONYX-I: Safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir in asian adults with genotype 1b chronic hepatitis C virus (HCV) infection: A randomized, double-blind, placebocontrolled study

Authors
Category Primary study
ConferenceHepatology International
Year 2017
This article has no abstract
Epistemonikos ID: 1b276a5ca0bd0b786a0a32a05e93d9ab5149cf06
First added on: Apr 29, 2026